JDRF Center of Excellence
in Northern California

This Center is a cure accelerator and a high impact partnership combining the scientific expertise of Stanford University and the University of California, San Francisco (UCSF) within the collaborative structure and support that are hallmarks of JDRF. Investigators at the Center will seek to better understand and target the interactions between the immune system and the beta cell, in an effort to deliver first-generation, stem cell-based cures for T1D.

These world-class researchers will:

Discover and explain how immune cells interact with islets and beta cells in T1D
Generate islets and immune cells from stem cells as the basis for next-generation cell therapies
Develop an islet transplant protocol that will induce tolerance and not require immunosuppression

Research Team

“One of the central challenges in type 1 diabetes (T1D) has been identifying and targeting interactions required for autoimmune assault of human islets by immune cells. This team of superb and innovative investigators will combine novel hypotheses with modern tools to address such outstanding questions in type 1 diabetes (T1D) pathogenesis. We envision that successful investigations in this crucial area of T1D research by this CoE team will enable cell-based replacement therapies to move us closer to a cure for T1D.”

Dr. Matthias Hebrok,Ph.D., University of California, San Francisco,
Dr. Seung Kim, M.D., Ph.D., Stanford University, and
Andrew Rakeman, Ph.D., JDRF

News & Blogs

JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research at Stanford University and the University of California, San Francisco, to develop cures for T1D.

September 04, 2019

Read More
Research Progress Update

Read the latest Report from these labs

Download

Support our Work

Will Hall
Donor Relations Officer
JDRF
whall@jdrf.org

JDRF Center of Excellence in Northern California

These world-class researchers will:

Aaron J. Kowalski, Ph.D., JDRF

Esther Latres, Ph.D.,JDRF

Matthias Hebrok, Ph.D., UCSF

Seung Kim, M.D., Ph.D., Stanford University

Mark Anderson, M.D., Ph.D., UCSF

Jeffrey Bluestone, Ph.D., UCSF

Kyle Loh, Ph.D., Stanford University

Alexander Marson, M.D., Ph.D., UCSF

Everett Meyer, M.D., Ph.D., Stanford University

Audrey Parent, Ph.D., UCSF

Judith Shizuru, M.D., Stanford University

Julie Sneddon, Ph.D., UCSF

Qizhi Tang, Ph.D., UCSF

Linda Vo, Ph.D., UCSF

Jimmie Ye, Ph.D., UCSF

JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced the launch of the JDRF Northern California Center of Excellence, to accelerate high-impact research at Stanford University and the University of California, San Francisco, to develop cures for T1D.

Research Progress Update

Your privacy